Overexpression of BAD potentiates sensitivity to tumor necrosis factor-related apoptosis-inducing ligand treatment in the prostatic carcinoma cell line LNCaP

Molecular Cancer Research

Volumn 1, Issue 7, 2003, Pages 500-507

  Taghiyev, Agshin F ^a   Guseva, Natalya V ^a   Harada, Hisashi ^c   Knudson, C Michael ^a   Rokhlin, Oskar W ^a   Cohen, Michael B ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; CYTOCHROME C; PROTEIN; PROTEIN BAD; SECOND MITOCHONDRIAL ACTIVATOR OF CASPASE; SERINE; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; CYTOSOL; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MITOCHONDRION; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION;

ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BCL-ASSOCIATED DEATH PROTEIN; CARRIER PROTEINS; CASPASE 3; CASPASES; CELL SURVIVAL; CYTOSOL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MICE; MITOCHONDRIA; PHOSPHORYLATION; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0038732434     PISSN: 15417786     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. Wiley, S. R., Schooley, K., Smolak, P. J., Din, W. S., Huang, C. P., Nicholl, J. K., Sutherland, G. R., Smith, T. D., Rauch, C., Smith, C. A., and Goodwin, R. G. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity, 3 (6): 673-682, 1995.
2. Pitti, R. M., Masters, S. A., Rupper, S., Donahue, C. J., Moore, A., and Ashkenazi, A. Induction of apoptosis by Apo-2, a new member of the tumor necrosis factor receptor family. J. Biol. Chem., 271: 12687-12690, 1996.
3. Pan, G., O'Rourke, K., Chinnaiyan, A. M., Gentz, R., Ebner, R., Ni, J., and Dixit, V. M. The receptor for the cytotoxic ligand TRAIL. Science, 276 (5309): 111-113, 1997.
4. Pan, G., Ni, J., Wei, Y. F., Yu, G-L., Gentz, R., and Dixit, V. M. An antagonist decoy receptor and a new death domain-containing receptor for TRAIL. Science, 277: 815-818, 1997.
5. Sheridan, J. P., Marsters, S. A., Pitti, R. M., Gurney, A., Skubatch, M., Baldwin, D., Ramakrishnan, L., Gray, C. L., Baker, K., Wood, W. I., Goddard, A. D., Godowski, P., and Ashkenazi, A. Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science, 277 (5327): 818-821, 1997.
6. Screaton, G. R., Monkolsapaya, J., Xu, X. N., Cowper, A. E., McMichael, A. J., and Bell, J. I. TRICK2, a new alternatively spliced receptor that tranduces the cytotoxic signal from TRAIL. Curr. Biol., 7: 693-696, 1997.
7. Walczak, H., Degli-Esposti, M. A., Johnson, R. S., Smolak, P. J., Waugh, J. Y., Boiani, N., Timour, M. S., Gerhart, M. J., Schooley, K. A., Smith, C. A., Goodwin, R. G., and Rauch, C. T. TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL. EMBO J., 16 (17): 5386-5397, 1997.
8. Wu, G. S., Burns, T. F., McDonald, E. R., III, Jiang, W., Meng. R. Krantz, I. D., Kao, G., Gan, D. D., Zhou, J. Y., Muschel, R., Hamilton, S. R., Spinner, N. B., Markowitz, S., Wu, G., and el-Deiry, W. S. KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene. Nat. Genet., 17 (2): 141-143, 1997.
9. Sprick, M. R., Weigand, M. A., Rieser, E., Rauch, C. T., Juo, P., Blenis, J., Krammer, P. H., and Walczak, H. FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2. Immunity, 12 (6): 599-609, 2000.
10. Kischkel, F. C., Lawrence, D. A., Chuntharapai, A., Schow, P., Kim, K. J., and Ashkenazi, A. Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5. Immunity, 12 (6): 611-620, 2000.
11. Srivastava, R. K. TRAIL/Apo-2L: mechanisms and clinical applications in cancer (Review). Neoplasia, 3 (6): 535-546, 2001 Nov-Dec.
12. Snell, V., Clodi, K., Zhao, S., Goodwin, R., Thomas, E. K., Morris, S. W., Kadin, M. E., Cabanillas, F., Andreeff, M., and Younes, A. Activity of TNF-related apoptosis-inducing ligand (TRAIL) in haematological malignancies. Br. J. Haematol., 99 (3): 618-624, 1997.
13. Ashkenazi, A., Pai, R. C., Fong, S., Leung, S., Lawrence, D. A., Marsters, S. A., Blackie, C., Chang, L., McMurtrey, A. E., Hebert, A., DeForge, L., Koumenis, I. L., Lewis, D., Harris, L., Bussiere, J., Koeppen, H., Shahrokh, Z., and Schwall, R. H. Safety and antitumor activity of recombinant soluble Apo2 ligand. J. Clin. Invest., 104 (2): 155-162, 1999.
14. Walczak, H., Miller, R. E., Ariail, K., Gliniak, B., Griffith, T. S., Kubin, M., Chin, W., Jones, J., Woodward, A., Le, T., Smith, C., Smolak, P., Goodwin, R. G., Rauch, C. T., Schuh, J. C., and Lynch, D. H. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat. Med., 5 (2): 157-163, 1999.
15. Vassalli, P. The pathophysiology of tumor necrosis factors. Annu. Rev. Immunol., 10: 411-452, 1992.
16. Nagata, S. Apoptosis by death factor. Cell, 7; 88 (3): 355-365, 1997.
17. Griffith, T. S., Anderson, R. D., Davidson, B. L., Williams, R. D., and Ratliff, T. L. Adenoviral-mediated transfer of the TNF-related apoptosis-inducing ligand/Apo-2 ligand gene induces tumor cell apoptosis. J. Immunol., 165 (5): 2886-2894, 2000.
18. Yu, R., Mandlekar, S., Ruben, S., Ni, J., and Kong, A. N. Tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in androgen-independent prostate cancer cells. Cancer Res., 60 (9): 2384-2389, 2000.
19. Rokhlin, O. W., Guseva, N., Tagiyev, A., Knudson, C. M., and Cohen, M. B. Bcl-2 oncoprotein protects the human prostatic carcinoma cell line PC3 from TRAIL-mediated apoptosis. Oncogene, 20 (22): 2836-2843, 2001.
20. Chen, X., Thakkar, H., Tyan, F., Gim, S., Robinson, H., Lee, C., Pandey, S. K., Nwokorie, C., Onwudiwe, N., and Srivastava, R. K. Constitutively active Akt is an important regulator of TRAIL sensitivity in prostate cancer. Oncogene, 20 (42): 6073-6083, 2001.
21. Nesterov, A., Lu, X., Johnson, M., Miller, G. J., Ivashchenko, Y., and Kraft, A. S. Elevated AKT activity protects the prostate cancer cell line LNCaP from TRAIL-induced apoptosis. J. Biol. Chem., 276 (14): 10767-10774, 2001.
22. Munshi, A., Pappas, G., Honda, T., McDonnell, T. J., Younes, A., Li, Y., and Meyn, R. E. TRAIL (APO-2L) induces apoptosis in human prostate cancer cells that is inhibitable by Bcl-2. Oncogene, 20 (29): 3757-3765, 2001.
23. Nimmanapalli, R., Perkins, C. L., Orlando, M., O'Bryan, E., Nguyen, D., and Bhalla, K. N. Pretreatment with paclitaxel enhances apo-2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of prostate cancer cells by inducing death receptors 4 and 5 protein levels. Cancer Res., 61 (2): 759-763, 2001.
24. Rokhlin, O. W., Guseva, N. V., Tagiyev, A. F., Glover, R. A., and Cohen, M. B. Caspase-8 activation is necessary but not sufficient for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis in the prostatic carcinoma cell line LNCaP. Prostate, 52 (1): 1-11, 2001.
25. Nesterov, A., Ivashchenko, Y., and Kraft, A. S. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) triggers apoptosis in normal prostate epithelial cells. Oncogene, 21 (7): 1135-1140, 2002.
26. Vlietstra, R. J., van Alewijk, D. C., Hermans, K. G., van Steenbrugge, G. J., and Trapman, J. Frequent inactivation of PTEN in prostate cancer cell lines and xenografts. Cancer Res., 58 (13): 2720-2723, 1998.
27. Vivanco, I. and Sawyers, C. L. The phosphatidylinositol 3-kinase AKT pathway in human cancer. Nat. Rev. Cancer, 2 (7): 489-501, 2002.
28. Lin, J., Adam, R. M., Santiestevan, E., and Freeman, M. R. The phosphatidylinositol 3′-kinase pathway is a dominant growth factor-activated cell survival pathway in LNCaP human prostate carcinoma cells. Cancer Res., 59 (12): 2891-2897, 1999.
29. Yuan, X. J. and Whang, Y. E. PTEN sensitizes prostate cancer cells to death receptor-mediated and drug-induced apoptosis through a FADD-dependent pathway. Oncogene, 21 (2): 319-327, 2002.
30. Thakkar, H., Chen, X., Tyan, F., Gim, S., Robinson, H., Lee, C., Pandey, S. K., Nwokorie, C., Onwudiwe, N., and Srivastava, R. K. Pro-survival function of Akt/protein kinase B in prostate cancer cells: relationship with trail resistance. J. Biol. Chem., 276 (42): 38361-38369, 2001.
31. Gross, A., McDonnell, J. M., and Korsmeyer, S. J. BCL-2 family members and the mitochondria in apoptosis. Genes Dev., 13 (15): 1899-1911, 1999.
32. Zha, J., Harada, H., Yang, E., Jockel, J., and Korsmeyer, S. J. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L). Cell, 87 (4): 619-628, 1996.
33. Tan, Y., Demeter, M. R., Ruan, H., and Comb, M. J. BAD Ser-155 phosphorylation regulates BAD/Bcl-XL interaction and cell survival. J. Biol. Chem., 275 (33): 25865-25869, 2000.
34. Zhou, X. M., Liu, Y., Payne, G., Lutz, R. J., and Chittenden, T. Growth factors inactivate the cell death promoter BAD by phosphorylation of its BH3 domain on Ser155. J. Biol. Chem., 275 (32): 25046-25051, 2000.
35. Datta, S. R., Katsov, A., Hu, L., Petros, A., Fesik, S. W., Yaffe, M. B., and Greenberg, M. E. 14-3-3 proteins and survival kinases cooperate to inactivate BAD by BH3 domain phosphorylation. Mol. Cell, 6 (1): 41-51, 2000.
36. Lizcano, J. M., Morrice, N., and Cohen, P. Regulation of BAD by cAMP-dependent protein kinase is mediated via phosphorylation of a novel site, Ser155. Biochem. J., 349 (Pt. 2): 547-557, 2000.
37. Virdee, K., Parone, P. A., and Tolkovsky, A. M. Phosphorylation of the pro-apoptotic protein BAD on serine 155, a novel site, contributes to cell survival. Curt. Biol., 10 (18): 1151-1154, 2000.
38. Dramsi, S., Scheid, M. P., Maiti, A., Hojabrpour, P., Chen, X., Schubert, K., Goodlett, D. R., Aebersold, R., and Duronio, V. Identification of a novel phosphorylation site, Ser-170, as a regulator of BAD pro-apoptotic activity. J. Biol. Chem., 277 (8): 6399-6405, 2002.
39. del Peso, L., Gonzales-Garsia, M., Page, C., Herrera, R., and Nunez, G. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science, 278 (5338): 687-689, 1997.
40. Datta, S. R., Dudek, H., Tao, X., Masters, S., Fu, H., Gotoh, Y., and Greenberg, M. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell, 91 (2): 231-241, 1997.
41. Bonni, A., Brunet, A., West, A. E., Datta, S. R., Takasu, M. A., and Greenberg, M. E. Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms. Science, 286 (5443): 1358-1362, 1999.
42. Tan, Y., Ruan, H., Demeter, M. R., and Comb, M. J. p90(RSK) blocks BAD-mediated cell death via a protein kinase C-dependent pathway. J. Biol. Chem., 274 (49): 34859-34867, 1999.
43. Harada, H., Becknell, B., Wilm, M., Mann, M., Huang, L. J., Taylor, S. S., Scott, J. D., and Korsmeyer, S. J. Phosphorylation and inactivation of BAD by mitochondria-anchored protein kinase A. Mol. Cell, 3 (4): 413-422, 1999.
44. Hsu, S. Y., Kaipia, A., Zhu, L., and Hsueh, A. J. Interference of BAD (Bcl-xL/Bcl-2-associated death promoter)-induced apoptosis in mammalian cells by 14-3-3 isoforms and P11. Mol. Endocrinol., 11 (12): 1858-1867, 1997.
45. Condorelli, F., Salomoni, P., Cotteret, S., Cesi, V., Srinivasula, S. M., Alnemri, E. S., and Calabretta, B. Caspase cleavage enhances the apoptosis-inducing effects of BAD. Mol. Cell. Biol., 21 (9): 3025-3036, 2001.
46. Kim, B. C., Mamura, M., Choi, K. S., Calabretta, B., and Kim, S. J. Transforming growth factor β1 induces apoptosis through cleavage of BAD in a Smad3-dependent mechanism in FaO hepatoma cells. Mol. Cell. Biol., 22 (5): 1369-1378, 2002.
47. Kim, H. T., Kim, B. C., Kim, I. Y., Mamura, M., Seong, Do H., Jang, J. J., and Kim, S. J. Raloxifene, a mixed estrogen agonist/antagonist, induces apoptosis through cleavage of BAD in TSU-PR1 human cancer cells. J. Biol. Chem., 277 (36): 32510-32515, 2002.
48. Lazebnik, Y. A., Kaufmann, S. H., Desnoyers, S., Poirier, G. G., and Earnshaw, W. C. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature, 371 (6495): 346-347, 1994 Sep 22.
49. Van Loo, G., Saelens, X., Van Gurp, M., MacFarlane, M., Martin, S. J., and Vandenabeele, P. The role of mitochondrial factors in apoptosis: a Russian roulette with more than one bullet. Cell Death & Differ., 9 (10): 1031-1042, 2002 Oct.
50. Luo, X., Budihardjo, I., Zou, H., Slaughter, C., and Wang, X. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell, 94 (4): 481-490, 1998 Aug 21.
51. Yang, J., Liu, X., Bhalla, K., Kim, C. N., Ibrado, A. M., Cai, J., Peng, T. I., Jones, D. P., and Wang, X. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science, 275 (5303): 1129-1132, 1997 Feb 21.
52. Suliman, A., Lam, A., Datta, R., and Srivastava, R. K. Intracellular mechanisms of TRAIL: apoptosis through mitochondrial-dependent and -independent pathways. Oncogene, 20 (17): 2122-2133, 2001 Apr 19.
53. Finucane, D. M., Bossy-Wetzel, E., Waterhouse, N. J., Cotter, T. G., and Green, D. R. Bax-induced caspase activation and apoptosis via cytochrome c release from mitochondria is inhibitable by Bcl-xL. J. Biol. Chem., 274 (4): 2225-2233, 1999 Jan 22.
54. Green, D. R. and Reed, J. C. Mitochondria and apoptosis (Review). Science, 281 (5381): 1309-1312, 1998 Aug 28.
55. Korsmeyer, S. J., Wei, M. C., Saito, M., Weiler, S., Oh, K. J., and Schlesinger, P. H. Pro-apoptotic cascade activates BID, which oligomerizes BAK or BAX into pores that result in the release of cytochrome c (Review). Cell Death & Differ., 7 (12): 1166-1173, 2000 Dec.
56. Verhagen, A. M., Ekert, P. G., Pakusch, M., Silke, J., Connolly, L. M., Reid, G. E., Moritz, R. L., Simpson, R. J., and Vaux, D. L. Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell, 102 (1): 43-53, 2000 Jul 7.
57. Du, C., Fang, M., Li, Y., Li, L., and Wang, X. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell, 102 (1): 33-42, 2000 Jul 7.
58. Susin, S. A., Lorenzo, H. K., Zamzami, N., Marzo, I., Snow, B. E., Brothers, G. M., Mangion, J., Jacotot, E., Costantini, P., Loeffler M., Larochette, N., Goodlett, D. R., Aebersold, R., Siderovski, D. P., Penninger, J. M., and Kroemer, G. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature, 397 (6718): 441-446, 1999 Feb 4.
59. Hegde, R., Srinivasula, S. M., Zhang, Z., Wassell, R., Mukattash, R., Cilenti, L., DuBois, G., Lazebnik, Y., Zervos, A. S., Fernandes-Alnemri, T., and Alnemri, E. S. Identification of Omi/HtrA2 as a mitochondrial apoptotic serine protease that disrupts inhibitor of apoptosis protein-caspase interaction. J. Biol. Chem., 277 (1): 432-438, 2002 Jan 4.
60. Hirai, I. and Wang, H-G. Survival-factor-induced phosphorylation of BAD results in its dissociation from Bcl-xL but not Bcl-2. Biochem. J., 359: 345-352, 2001.
61. She, Q. B., Ma, W. Y., Zhong, Sh., and Dong, Z. Activation of JNK1, RSK2, and MSKI is involved in serine 112 phosphorylation of Bad by ultraviolet B radiation. J. Biol. Chem., 277 (27): 24039-24048, 2002 Jul 5.
62. Masters, S. C., Yang, H., Datta, S. R., Greenberg, M. E., and Fu, H. 14-3-3 inhibits Bad-induced cell death through interaction with serine-136. Mol. Pharmacol., 60 (6): 1325-1331, 2001 Dec.
63. Garcia-Calvo, M., Peterson, E. P., Leiting, B., Ruel, R., Nicholson, D. W., and Thornberry, N. A. Inhibition of human caspases by peptide-based and macromolecular inhibitors. J. Biol. Chem., 273 (49): 32608-32613, 1998 Dec 4.